Biomaterials · 2022 · 58 citations · 20 references
Life SciencesCancer BiologyImmunologyCancer ImmunologyImmunotherapyTumor ImmunologyAntitumor T Cell ResponsesCancer ImmunotherapyCell-mediated ImmunityLysosomal DegradationLysosome BiologyT Cell BiologyAdaptive Antitumor ImmunityLysosomal Cargo DegradationLysosomal Degradation PathwaysPd-l1 BlockadeProgrammed Cell Death Protein 1 (Pd-1) PathwayProgrammed Death-ligand 1 TargetingT-cell Mediated Immunity
20
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon, Roy L. Maute, Ben W. Dulken et al. · Nature · 2017 · 2.3K citations · Full text
Life Sciences, Immunology, Oncology +16
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L. Burr, Christina E. Sparbier, Yih-Chih Chan et al. · Nature · 2017 · 950 citations · Full text
Medicine, Immunology, Oncology +12
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
Riccardo Mezzadra, Chong Sun, Lucas T. Jae et al. · Nature · 2017 · 703 citations · Full text
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
Han Yao, Chushu Li, Hubing Shi et al. · Nature Biomedical Engineering · 2019 · 561 citations
Life Sciences, Immunology, Oncology +14